Cite
Antibodies to Crohn's disease peptide 353 as a diagnostic marker for pediatric Crohn's disease: a prospective multicenter study in Japan.
MLA
Mizuochi, Tatsuki, et al. “Antibodies to Crohn’s Disease Peptide 353 as a Diagnostic Marker for Pediatric Crohn’s Disease: A Prospective Multicenter Study in Japan.” Journal of Gastroenterology, vol. 55, no. 5, May 2020, pp. 515–22. EBSCOhost, https://doi.org/10.1007/s00535-019-01661-y.
APA
Mizuochi, T., Arai, K., Kudo, T., Nambu, R., Tajiri, H., Aomatsu, T., Abe, N., Kakiuchi, T., Hashimoto, K., Sogo, T., Takahashi, M., Etani, Y., Takaki, Y., Konishi, K., Ishihara, J., Obara, H., Kakuma, T., Kurei, S., Yamashita, Y., & Mitsuyama, K. (2020). Antibodies to Crohn’s disease peptide 353 as a diagnostic marker for pediatric Crohn’s disease: a prospective multicenter study in Japan. Journal of Gastroenterology, 55(5), 515–522. https://doi.org/10.1007/s00535-019-01661-y
Chicago
Mizuochi, Tatsuki, Katsuhiro Arai, Takahiro Kudo, Ryusuke Nambu, Hitoshi Tajiri, Tomoki Aomatsu, Naoki Abe, et al. 2020. “Antibodies to Crohn’s Disease Peptide 353 as a Diagnostic Marker for Pediatric Crohn’s Disease: A Prospective Multicenter Study in Japan.” Journal of Gastroenterology 55 (5): 515–22. doi:10.1007/s00535-019-01661-y.